We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

1
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.82M
2
UNH icon
UnitedHealth
UNH
+$3.15M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
351
CALL
Tesla
TSLA
$1.43T
$130 ﹤0.01%
7
-3
-30% -$1.33K
ATYR
352
CALL
aTyr Pharma
ATYR
$50M
$129 ﹤0.01%
36
-261
-88% -$214
CAT icon
353
CALL
Caterpillar
CAT
$405B
$72 ﹤0.01%
+9
New +$5K
MREO
354
CALL
Mereo BioPharma
MREO
$49.5M
$57 ﹤0.01%
5,359
+1,858
+53% +$3.54K
GS icon
355
CALL
Goldman Sachs
GS
$314B
$36 ﹤0.01%
+2
New +$1.63K
EDIT icon
356
CALL
Editas Medicine
EDIT
$457M
$34 ﹤0.01%
862
+169
+24% +$488
RXRX icon
357
CALL
Recursion Pharmaceuticals
RXRX
$1.56B
$20 ﹤0.01%
1,999
+393
+24% +$1.95K
ALT icon
358
CALL
Altimmune
ALT
$558M
$13 ﹤0.01%
1,324
+260
+24% +$1.13K
VTGN icon
359
CALL
VistaGen Therapeutics
VTGN
$9.4M
$3 ﹤0.01%
287
+56
+24% +$202
APLT
360
CALL
DELISTED
Applied Therapeutics
APLT
$1 ﹤0.01%
55
+11
+25% +$7
ZYME icon
361
PUT
Zymeworks
ZYME
$1.78B
$1 ﹤0.01%
+57
New +$1.24K
AAPL icon
362
CALL
Apple
AAPL
$4.9T
– –
-140
Closed -$16.1K
ABR icon
363
Arbor Realty Trust
ABR
$996M
– –
-45,455
Closed -$446K
ACAD icon
364
CALL
Acadia Pharmaceuticals
ACAD
$4.38B
– –
-204
Closed -$11.9K
ADUS icon
365
Addus HomeCare
ADUS
$2.14B
– –
-2,259
Closed -$267K
AEVA
366
CALL
Aeva Technologies
AEVA
$1.14B
– –
-20
Closed -$1.25K
AFRM icon
367
CALL
Affirm
AFRM
$25.5B
– –
-23
Closed -$9.26K
AGIO icon
368
CALL
Agios Pharmaceuticals
AGIO
$2.36B
– –
-546
Closed -$291K
AGNC icon
369
AGNC Investment
AGNC
$12.9B
– –
-40,908
Closed -$421K
ALEC icon
370
Alector
ALEC
$167M
– –
-31,240
Closed -$92.5K
ALKS icon
371
Alkermes
ALKS
$8.79B
– –
-16,541
Closed -$496K
ANAB icon
372
AnaptysBio
ANAB
$1.72B
– –
-754
Closed -$23.1K
ARCT icon
373
Arcturus Therapeutics
ARCT
$172M
– –
-11,189
Closed -$206K
ARCT icon
374
PUT
Arcturus Therapeutics
ARCT
$172M
– –
-345
Closed -$38.6K
AUPH icon
375
PUT
Aurinia Pharmaceuticals
AUPH
$2.05B
– –
-3
Closed -$118
13 14
15
16 17

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.